<p>Artelo Biosciences Inc. has announced that its 2025 Annual Meeting of Stockholders will be held via internet webcast on December 31, 2025. During the meeting, stockholders will vote on the election of two Class II director nominees, Douglas Blayney, M.D., and Connie Matsui, to serve on the Board until the 2028 Annual Meeting of Stockholders. Additionally, stockholders will vote on the approval, on an advisory basis, of the compensation of the named executive officers identified in the 2024 Summary Compensation Table. The meeting will also address any other business that may be properly brought before the Annual Meeting or any adjournments or postponements thereof. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artelo Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001640334-25-002308), on December 11, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

ARTL

<p>Artelo Biosciences Inc. will hold its 2025 Annual Meeting of Stockholders via webcast on December 31, 2025. Stockholders will vote on the election of two Class II director nominees and the approval of executive compensation. The meeting will also address other business matters. This announcement was made via EDGAR by Artelo Biosciences Inc.</p>

Artelo Biosciences Inc. Announces Date for 2025 Annual Meeting of Stockholders